miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression
Corcoran, Claire, Rani, Sweta, O'Driscoll, LorraineVolume:
74
Language:
english
Journal:
The Prostate
DOI:
10.1002/pros.22848
Date:
September, 2014
File:
PDF, 541 KB
english, 2014